BIOA vs MBX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 03, 2026

BIOA

39.3
AI Score
VS
MBX Wins

MBX

57.4
AI Score

Investment Advisor Scores

BIOA

39score
Recommendation
SELL

MBX

57score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric BIOA MBX Winner
Net Income -80.61M -60.61M MBX
Operating Income -92.78M -68.20M MBX
ROE -29.6% -14.8% MBX
ROA -27.3% -13.9% MBX
Total Assets 294.89M 435.91M MBX
Cash 188.89M 54.12M BIOA
Current Ratio 14.24 18.08 MBX
Free Cash Flow -82.35M -44.17M MBX

Relative Price Performance (Last 90 Days)

BIOA 1M: -32.1% · 3M: -73.4% MBX 1M: -3.9% · 3M: +1.4%

Current Technical Phase

BIOA

Markdown
Sell / avoid

Price below a falling SMA50 (slope -36.9%), weak momentum, RSI 25

RSI (14): 25.1 · Price: $6.61

MBX

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 46

RSI (14): 46.3 · Price: $58.51

Fundamentals Snapshot

Metric BIOA MBX
Market Cap — —
Forward P/E -2.7 -14.7
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.0% 0.0%
Gross Margin -7.5% —
Operating Margin -12.0% 0.0%
EPS -2.29 -2.28
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, MBX is currently the stronger investment candidate, winning 7 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.